The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Veterinary Clostridium Vaccine Market Research Report 2025

Global Veterinary Clostridium Vaccine Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1908061

No of Pages : 102

Ask Your Query
Synopsis
A clostridial vaccine is a vaccine for sheep and cattle that protects against diseases caused by toxins produced by an infection with one or more Clostridium bacteria.
The global Veterinary Clostridium Vaccine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
According to Our PET Supplies Research Center, the global pet industry reached $ 261 billion in 2022, a year-on-year increase of 11.3%. The United States gains the highest pet penetration rate and becomes the largest pet market. According to the American Pet Products Association (APPA), 66% of American households keep pets, and the total industry sales was about US$136.8 billion, an increase of 10.8% over 2021. According to IVH, the German pet products industry association, the number of pets in Germany reached 33.4 million in 2022, with a total turnover of nearly €6.5 billion. The 2023 China Pet Industry Trend Insight White Paper released by JD shows that the market size of the four major pet physical commodities is increasing year by year: pet supplies account for 45%, pet staple food accounts for nearly 35%, pet snacks account for 12%, and pet medicine and health care account for 105%.
This report aims to provide a comprehensive presentation of the global market for Veterinary Clostridium Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Veterinary Clostridium Vaccine.
Report Scope
The Veterinary Clostridium Vaccine market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Veterinary Clostridium Vaccine market comprehensively. Regional market sizes, concerning products by Objects, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Veterinary Clostridium Vaccine companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Objects, by Application, and by regions.
Market Segmentation
By Company
Elanco
Merck
Merial
Zoetis
Advaxis
Ampliphi
Aratana Therapeutics
ARKO Labs
Bayer
CanFel Therapeutics
Ceva
Colorado Serum
Epitopix
Genus
Hygieia Biological Laboratories
Nexvet
Nuovo Biologics
Valneva
Vetoquinol
Virbac
Segment by Objects
Bovine
Ovine
Caprine
Swine
Poultry
Segment by Application
Veterinary Clinic
Veterinary Hospital
Veterinary Research Institute
Retail Pharmacy
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Objects, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Veterinary Clostridium Vaccine companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Objects, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Objects
1.2.1 Global Veterinary Clostridium Vaccine Market Size Growth Rate by Objects: 2019 VS 2023 VS 2030
1.2.2 Bovine
1.2.3 Ovine
1.2.4 Caprine
1.2.5 Swine
1.2.6 Poultry
1.3 Market by Application
1.3.1 Global Veterinary Clostridium Vaccine Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Veterinary Clinic
1.3.3 Veterinary Hospital
1.3.4 Veterinary Research Institute
1.3.5 Retail Pharmacy
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Veterinary Clostridium Vaccine Market Perspective (2019-2030)
2.2 Veterinary Clostridium Vaccine Growth Trends by Region
2.2.1 Global Veterinary Clostridium Vaccine Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Veterinary Clostridium Vaccine Historic Market Size by Region (2019-2024)
2.2.3 Veterinary Clostridium Vaccine Forecasted Market Size by Region (2025-2030)
2.3 Veterinary Clostridium Vaccine Market Dynamics
2.3.1 Veterinary Clostridium Vaccine Industry Trends
2.3.2 Veterinary Clostridium Vaccine Market Drivers
2.3.3 Veterinary Clostridium Vaccine Market Challenges
2.3.4 Veterinary Clostridium Vaccine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Veterinary Clostridium Vaccine Players by Revenue
3.1.1 Global Top Veterinary Clostridium Vaccine Players by Revenue (2019-2024)
3.1.2 Global Veterinary Clostridium Vaccine Revenue Market Share by Players (2019-2024)
3.2 Global Veterinary Clostridium Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Veterinary Clostridium Vaccine Revenue
3.4 Global Veterinary Clostridium Vaccine Market Concentration Ratio
3.4.1 Global Veterinary Clostridium Vaccine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Veterinary Clostridium Vaccine Revenue in 2023
3.5 Veterinary Clostridium Vaccine Key Players Head office and Area Served
3.6 Key Players Veterinary Clostridium Vaccine Product Solution and Service
3.7 Date of Enter into Veterinary Clostridium Vaccine Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Veterinary Clostridium Vaccine Breakdown Data by Objects
4.1 Global Veterinary Clostridium Vaccine Historic Market Size by Objects (2019-2024)
4.2 Global Veterinary Clostridium Vaccine Forecasted Market Size by Objects (2025-2030)
5 Veterinary Clostridium Vaccine Breakdown Data by Application
5.1 Global Veterinary Clostridium Vaccine Historic Market Size by Application (2019-2024)
5.2 Global Veterinary Clostridium Vaccine Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Veterinary Clostridium Vaccine Market Size (2019-2030)
6.2 North America Veterinary Clostridium Vaccine Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Veterinary Clostridium Vaccine Market Size by Country (2019-2024)
6.4 North America Veterinary Clostridium Vaccine Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Veterinary Clostridium Vaccine Market Size (2019-2030)
7.2 Europe Veterinary Clostridium Vaccine Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Veterinary Clostridium Vaccine Market Size by Country (2019-2024)
7.4 Europe Veterinary Clostridium Vaccine Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Veterinary Clostridium Vaccine Market Size (2019-2030)
8.2 Asia-Pacific Veterinary Clostridium Vaccine Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Veterinary Clostridium Vaccine Market Size by Region (2019-2024)
8.4 Asia-Pacific Veterinary Clostridium Vaccine Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Veterinary Clostridium Vaccine Market Size (2019-2030)
9.2 Latin America Veterinary Clostridium Vaccine Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Veterinary Clostridium Vaccine Market Size by Country (2019-2024)
9.4 Latin America Veterinary Clostridium Vaccine Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Veterinary Clostridium Vaccine Market Size (2019-2030)
10.2 Middle East & Africa Veterinary Clostridium Vaccine Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Veterinary Clostridium Vaccine Market Size by Country (2019-2024)
10.4 Middle East & Africa Veterinary Clostridium Vaccine Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Elanco
11.1.1 Elanco Company Detail
11.1.2 Elanco Business Overview
11.1.3 Elanco Veterinary Clostridium Vaccine Introduction
11.1.4 Elanco Revenue in Veterinary Clostridium Vaccine Business (2019-2024)
11.1.5 Elanco Recent Development
11.2 Merck
11.2.1 Merck Company Detail
11.2.2 Merck Business Overview
11.2.3 Merck Veterinary Clostridium Vaccine Introduction
11.2.4 Merck Revenue in Veterinary Clostridium Vaccine Business (2019-2024)
11.2.5 Merck Recent Development
11.3 Merial
11.3.1 Merial Company Detail
11.3.2 Merial Business Overview
11.3.3 Merial Veterinary Clostridium Vaccine Introduction
11.3.4 Merial Revenue in Veterinary Clostridium Vaccine Business (2019-2024)
11.3.5 Merial Recent Development
11.4 Zoetis
11.4.1 Zoetis Company Detail
11.4.2 Zoetis Business Overview
11.4.3 Zoetis Veterinary Clostridium Vaccine Introduction
11.4.4 Zoetis Revenue in Veterinary Clostridium Vaccine Business (2019-2024)
11.4.5 Zoetis Recent Development
11.5 Advaxis
11.5.1 Advaxis Company Detail
11.5.2 Advaxis Business Overview
11.5.3 Advaxis Veterinary Clostridium Vaccine Introduction
11.5.4 Advaxis Revenue in Veterinary Clostridium Vaccine Business (2019-2024)
11.5.5 Advaxis Recent Development
11.6 Ampliphi
11.6.1 Ampliphi Company Detail
11.6.2 Ampliphi Business Overview
11.6.3 Ampliphi Veterinary Clostridium Vaccine Introduction
11.6.4 Ampliphi Revenue in Veterinary Clostridium Vaccine Business (2019-2024)
11.6.5 Ampliphi Recent Development
11.7 Aratana Therapeutics
11.7.1 Aratana Therapeutics Company Detail
11.7.2 Aratana Therapeutics Business Overview
11.7.3 Aratana Therapeutics Veterinary Clostridium Vaccine Introduction
11.7.4 Aratana Therapeutics Revenue in Veterinary Clostridium Vaccine Business (2019-2024)
11.7.5 Aratana Therapeutics Recent Development
11.8 ARKO Labs
11.8.1 ARKO Labs Company Detail
11.8.2 ARKO Labs Business Overview
11.8.3 ARKO Labs Veterinary Clostridium Vaccine Introduction
11.8.4 ARKO Labs Revenue in Veterinary Clostridium Vaccine Business (2019-2024)
11.8.5 ARKO Labs Recent Development
11.9 Bayer
11.9.1 Bayer Company Detail
11.9.2 Bayer Business Overview
11.9.3 Bayer Veterinary Clostridium Vaccine Introduction
11.9.4 Bayer Revenue in Veterinary Clostridium Vaccine Business (2019-2024)
11.9.5 Bayer Recent Development
11.10 CanFel Therapeutics
11.10.1 CanFel Therapeutics Company Detail
11.10.2 CanFel Therapeutics Business Overview
11.10.3 CanFel Therapeutics Veterinary Clostridium Vaccine Introduction
11.10.4 CanFel Therapeutics Revenue in Veterinary Clostridium Vaccine Business (2019-2024)
11.10.5 CanFel Therapeutics Recent Development
11.11 Ceva
11.11.1 Ceva Company Detail
11.11.2 Ceva Business Overview
11.11.3 Ceva Veterinary Clostridium Vaccine Introduction
11.11.4 Ceva Revenue in Veterinary Clostridium Vaccine Business (2019-2024)
11.11.5 Ceva Recent Development
11.12 Colorado Serum
11.12.1 Colorado Serum Company Detail
11.12.2 Colorado Serum Business Overview
11.12.3 Colorado Serum Veterinary Clostridium Vaccine Introduction
11.12.4 Colorado Serum Revenue in Veterinary Clostridium Vaccine Business (2019-2024)
11.12.5 Colorado Serum Recent Development
11.13 Epitopix
11.13.1 Epitopix Company Detail
11.13.2 Epitopix Business Overview
11.13.3 Epitopix Veterinary Clostridium Vaccine Introduction
11.13.4 Epitopix Revenue in Veterinary Clostridium Vaccine Business (2019-2024)
11.13.5 Epitopix Recent Development
11.14 Genus
11.14.1 Genus Company Detail
11.14.2 Genus Business Overview
11.14.3 Genus Veterinary Clostridium Vaccine Introduction
11.14.4 Genus Revenue in Veterinary Clostridium Vaccine Business (2019-2024)
11.14.5 Genus Recent Development
11.15 Hygieia Biological Laboratories
11.15.1 Hygieia Biological Laboratories Company Detail
11.15.2 Hygieia Biological Laboratories Business Overview
11.15.3 Hygieia Biological Laboratories Veterinary Clostridium Vaccine Introduction
11.15.4 Hygieia Biological Laboratories Revenue in Veterinary Clostridium Vaccine Business (2019-2024)
11.15.5 Hygieia Biological Laboratories Recent Development
11.16 Nexvet
11.16.1 Nexvet Company Detail
11.16.2 Nexvet Business Overview
11.16.3 Nexvet Veterinary Clostridium Vaccine Introduction
11.16.4 Nexvet Revenue in Veterinary Clostridium Vaccine Business (2019-2024)
11.16.5 Nexvet Recent Development
11.17 Nuovo Biologics
11.17.1 Nuovo Biologics Company Detail
11.17.2 Nuovo Biologics Business Overview
11.17.3 Nuovo Biologics Veterinary Clostridium Vaccine Introduction
11.17.4 Nuovo Biologics Revenue in Veterinary Clostridium Vaccine Business (2019-2024)
11.17.5 Nuovo Biologics Recent Development
11.18 Valneva
11.18.1 Valneva Company Detail
11.18.2 Valneva Business Overview
11.18.3 Valneva Veterinary Clostridium Vaccine Introduction
11.18.4 Valneva Revenue in Veterinary Clostridium Vaccine Business (2019-2024)
11.18.5 Valneva Recent Development
11.19 Vetoquinol
11.19.1 Vetoquinol Company Detail
11.19.2 Vetoquinol Business Overview
11.19.3 Vetoquinol Veterinary Clostridium Vaccine Introduction
11.19.4 Vetoquinol Revenue in Veterinary Clostridium Vaccine Business (2019-2024)
11.19.5 Vetoquinol Recent Development
11.20 Virbac
11.20.1 Virbac Company Detail
11.20.2 Virbac Business Overview
11.20.3 Virbac Veterinary Clostridium Vaccine Introduction
11.20.4 Virbac Revenue in Veterinary Clostridium Vaccine Business (2019-2024)
11.20.5 Virbac Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock